Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 06/15/18 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
58 | |
| 06/15/18 | 8-K | Current report filing |
|
5 | |
| 06/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/12/18 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
